Cancer Screening
Screen for leukemia resistance identified mutation pattern for PD166326
Published in Gene Therapy Weekly, April 14th, 2005
According to recent research published in the journal Blood, "In Philadelphia-positive (Ph) leukemia, point mutations within the Bcr-Abl kinase domain emerged as a major mechanism of resistance to imatinib mesylate. We established a cell-based screening strategy for detection of clinically relevant point mutations using Bcr-Abl-transformed Ba/F3 cells. We identified 32 different single-point mutations within the kinase domain of Bcr-Abl."
"The pattern and frequency of mutations in this cell culture-based screen resembled the pattern and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-04-14)
More Articles from Gene Therapy Weekly
- Diabetes Therapy
Beta-cells that secrete GLP-1 have improved glucose-responsiveness - Gene Transfer
The decorin transgene stops breast cancer metastasis - Hematology
Adeno-associated virus-mediated gene transfer fuels erythropoietin production - Oncology
Gene-loaded dendritic cells kindle a response to breast cancer antigens - Oncology
Melanoma differentiation-associated-7 gene transfer eradicates prostate cancer - Adult T-Cell Leukemia
TSLC1 overexpression may be a molecular marker for acute-type ATL - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
